Goldman Sachs analyst Rajan Sharma introduced a Buy rating and $13.50 price target for Immatics (IMTX) after previously being Not Rated on the early-stage biotech company. The firm is positive on ...
Goldman Sachs assumed coverage of Frontier Communications (FYBR) with a Not Rated. The firm assumed assumed coverage of eight stocks in U.S. telecom and cable, saying 2026 will likely be a pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback